US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

270.08

+4.081.53%

Volume:81.03K

Turnover:22.22M

Market Cap:506.25M

PE:- -

High:278.96

Open:269.96

Low:269.18

Close:266.00

52wk High:341.93

52wk Low:74.95

Shares:1.87M

Float Shares:1.87M

Volume Ratio:2.25

T/O Rate:4.32%

Dividend:1.00

Dividend Rate:0.37%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts’ Top Healthcare Picks: uniQure (QURE), Alumis Inc. (ALMS)

Analysts Are Bullish on Top Healthcare Stocks: Revolution Medicines (RVMD), Teva Pharmaceutical (TEVA)

J.P. Morgan’s Salveen Richter Reiterates Buy on Teva, Citing TEV-408 Phase 2a Success and Pipeline-in-a-Product Potential

Liquidia Gains FDA Fast Track for YUTREPIA in Raynaud’s

Press Release: PRF Technologies Provides First Half 2026 Business Update Highlighting Significant Progress Across Healthcare and AI Energy Business

Nexalin Technology Announces New Secondary Analysis of Previously Published Clinical Trial Data Reveals Previously Unreported Improvements in Memory, Comprehension and Language Function in Alzheimer’s Patients; ADAS-Cog Subscale Analysis to Guide Design of Planned U.S. Alzheimer’s Pilot Study

Modular Medical’s Pivot insulin delivery system enhancements cleared by FDA

SRX Global Provides Shareholder Update on Portfolio Company, ARMR Sciences, a Clinical-Stage Biodefense Company

Replimune to Present at the Cantor Global Healthcare Conference 2026

Altimmune to Participate in the Wells Fargo 21st Annual Healthcare Conference

Tectonic Therapeutic to Participate in the Morgan Stanley Global Healthcare Conference

Grace Therapeutics to Participate in the H.C. Wainright 28th Annual Global Investment Conference

Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and Lifecore Biomedical (LFCR)

DiagnosTear Seeks FDA Guidance for TeaRx Red Eye Diagnostic Test

Liquidia granted Fast Track designation to Yutrepia inhalation powder

Analysts Conflicted on These Healthcare Names: Definitive Healthcare Corp (DH) and Entrada Therapeutics Inc (TRDA)

American Healthcare REIT acquires eight senior housing communities for $696M

EPF Trims IHH Healthcare Stake but Retains Strong Institutional Holding

BioLargo subsidiary adds third distribution channel, accelerate ViaClyr rollout

Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST) and Alumis Inc. (ALMS)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/LABU/news?page=12"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":270.075,"timestamp":1789136836233,"preClose":266,"halted":0,"volume":81029,"delay":0,"changeRate":0.015319548872180408,"floatShares":1874486,"shares":1874486,"eps":0,"marketStatus":"Trading","change":4.075,"latestTime":"09-11 10:27:44 EDT","open":269.9644,"high":278.9613,"low":269.18,"amount":22223753.33477,"amplitude":0.036772,"askPrice":270.57,"askSize":120,"bidPrice":269.49,"bidSize":30,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789156800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":266,"sharesOutstanding":3074486,"nav":278.651,"aum":522328218.83,"dividendRate":0.003719,"bidAskSpread":0.002964,"preHourTrading":{"tag":"盘前","latestPrice":274.69,"preClose":266,"latestTime":"09:28 EDT","volume":2486,"amount":673283.80262,"timestamp":1789133308224,"change":8.69,"changeRate":0.032669,"amplitude":0.031541},"postHourTrading":{"tag":"盘后","latestPrice":264.12,"preClose":266,"latestTime":"19:53 EDT","volume":1904,"amount":504475.6573,"timestamp":1789084425326,"change":-1.88,"changeRate":-0.007068,"amplitude":0.00782},"volumeRatio":2.251938,"impliedVol":0.8685,"impliedVolPercentile":0.2988},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1874486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.251938,"shares":1874486,"dividePrice":1.0045,"high":278.9613,"amplitude":0.036772,"preClose":266,"low":269.18,"week52Low":74.95,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":270.075,"committee":-0.6,"eps":0,"divideRate":0.003719,"volume":81029,"delay":0,"ttmEps":0,"open":269.9644,"prevYearClose":159.39,"prevWeekClose":303.55,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":305.86,"twentyDayClose":273.91,"sixtyDayClose":184.63},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:12,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664808827","title":"Analysts’ Top Healthcare Picks: uniQure (QURE), Alumis Inc. (ALMS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664808827","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664808827?lang=en_us&edition=fundamental","pubTime":"2026-09-03 22:30","pubTimestamp":1788445821,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on uniQure (QURE), Alumis Inc. (ALMS) and Omnicell (OMC...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-uniqure-qure-alumis-inc-alms-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-uniqure-qure-alumis-inc-alms-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","QURE","BK4007","BK4139","LU0128526141.USD","BK4137","BK4581","LU0029874061.USD","LU0320765992.SGD","ALMS","BK4588","LABU","XLV","HCSG","BK4585","XBI","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664704888","title":"Analysts Are Bullish on Top Healthcare Stocks: Revolution Medicines (RVMD), Teva Pharmaceutical (TEVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664704888","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664704888?lang=en_us&edition=fundamental","pubTime":"2026-09-03 22:10","pubTimestamp":1788444623,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Revolution Medicines (RVMD) and Teva Pharmaceutical ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-revolution-medicines-rvmd-teva-pharmaceutical-teva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-revolution-medicines-rvmd-teva-pharmaceutical-teva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LABU","CANC","IE0002141913.USD","IE00B2B36J28.USD","BK4581","IE00B4R5TH58.HKD","LU0109394709.USD","LU0889565916.HKD","BK4596","LU0128526141.USD","RVMD","TEVA","BK4139","LU2324357040.USD","BK4557","IDNA","IE0009354923.USD","BK4588","PTH","HCSG","IE00BJT1NW94.SGD","BK4559","BK4566","IE00BJJMRZ35.SGD","IE0009355771.USD","LU0320765992.SGD","BK4137","BK4585","XBI","XLV","LU0029874061.USD","BBH","LU1983299246.USD","IE00BFTCPJ56.SGD","BK4584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664877405","title":"J.P. Morgan’s Salveen Richter Reiterates Buy on Teva, Citing TEV-408 Phase 2a Success and Pipeline-in-a-Product Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2664877405","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664877405?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:25","pubTimestamp":1788441955,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Salveen Richter from Goldman Sachs ma...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/j-p-morgans-salveen-richter-reiterates-buy-on-teva-citing-tev-408-phase-2a-success-and-pipeline-in-a-product-potential-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/j-p-morgans-salveen-richter-reiterates-buy-on-teva-citing-tev-408-phase-2a-success-and-pipeline-in-a-product-potential-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4504","LU1720051017.SGD","LU1894683264.USD","LU0912757837.SGD","LU1144417596.USD","LABU","LU2487616109.SGD","LU0528227936.USD","BK4557","IE0004091025.USD","LU1988902786.USD","LU2237443895.HKD","LU0971096721.USD","LU2324357040.USD","IE00BSNM7G36.USD","LU0096364046.USD","LU1244550577.SGD","LU2471134879.HKD","LU2265009873.SGD","BK4566","IE0002270589.USD","LU2089283258.USD","LU2896262040.SGD","LU2237443549.SGD","IE00BZ1G4Q59.USD","GSX","LU2237438978.USD","IE0034235188.USD","LU1989772840.SGD","KBWB","LU2237443465.HKD","TEVA","LU0314104364.USD","IE0004086264.USD","IE00BKVL7J92.USD","BK4516","BK4533","LU0882574139.USD","LU0345770993.USD","LU1868836757.USD","LU2264538146.SGD","XBI","LU0942090050.USD","LU0210528500.USD","LU1989772923.USD","BK4581","IAI","LU0006306889.USD","LU1791710582.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664724108","title":"Liquidia Gains FDA Fast Track for YUTREPIA in Raynaud’s","url":"https://stock-news.laohu8.com/highlight/detail?id=2664724108","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664724108?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:51","pubTimestamp":1788439872,"startTime":"0","endTime":"0","summary":"Liquidia Technologies ( ($LQDA) ) has provided an announcement. On September 3, 2026, Liquidia Corporation announced that the U.S. Food and Drug Ad...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/liquidia-gains-fda-fast-track-for-yutrepia-in-raynauds?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/liquidia-gains-fda-fast-track-for-yutrepia-in-raynauds?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664747838","title":"Press Release: PRF Technologies Provides First Half 2026 Business Update Highlighting Significant Progress Across Healthcare and AI Energy Business","url":"https://stock-news.laohu8.com/highlight/detail?id=2664747838","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664747838?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:30","pubTimestamp":1788438600,"startTime":"0","endTime":"0","summary":"for OcuRing-K, enabling initiation of a multi-center Phase II. clinical trial in the United States in patients undergoing cataract. surgery, with patient enrollment expected in the second half of 2026.-- Reported that PRF-110 demonstrated sustained 72-hour analgesic activity. extended-release benchmark, in a validated porcine post-operative pain. -- Reported expanded results from the same head-to-head study showing slower. systemic absorption, enhanced local tissue retention and sustained. exposure for PRF-110, supporting its development as a. developed as a potential non-opioid option for the management of. -- Entered a commercial collaboration with Blade Ranger to pursue potential. enterprise DeepSolar engagements, each with a minimum scope of 150 MW,-- Strengthened the balance sheet to approximately $11.6 million in cash,short term deposits and cash equivalents as of June 30, 2026, providing. -- Validated DeepSolar Predict using real-world European utility-scale. production, weather","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTY","LU0029874061.USD","IND","BK4007","PRGS","XBI","LU0128526141.USD","BK4137","BK4581","BK4097","BK4585","BK4555","AIPO","VTHR","03160","BK4232","PRFX","BK4604","PRF","BK4099","R","XLV","HCSG","LABU","FRNW","BK4022","BK4588","TM","AGIX","LU2065732104.USD","QTOC","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664487711","title":"Nexalin Technology Announces New Secondary Analysis of Previously Published Clinical Trial Data Reveals Previously Unreported Improvements in Memory, Comprehension and Language Function in Alzheimer’s Patients; ADAS-Cog Subscale Analysis to Guide Design of Planned U.S. Alzheimer’s Pilot Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2664487711","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664487711?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:30","pubTimestamp":1788438600,"startTime":"0","endTime":"0","summary":"Further analysis of ADAS-Cog data from the Company’s randomized, sham-controlled clinical trial — previously published in the Journal of Alzheimer’s Disease and in Radiology — identifies specific impr","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/03/3355902/0/en/nexalin-technology-announces-new-secondary-analysis-of-previously-published-clinical-trial-data-reveals-previously-unreported-improvements-in-memory-comprehension-and-language-func.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","LABU","NXPG","NXPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664699874","title":"Modular Medical’s Pivot insulin delivery system enhancements cleared by FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2664699874","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664699874?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:15","pubTimestamp":1788437720,"startTime":"0","endTime":"0","summary":"Modular Medical (MODD) announced that the FDA has cleared a set of software enhancements to its Pivot insulin delivery system, further expanding th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/modular-medicals-pivot-insulin-delivery-system-enhancements-cleared-by-fda-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/modular-medicals-pivot-insulin-delivery-system-enhancements-cleared-by-fda-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","IGM","BK4082","MODD","VGT","BK4585","QQH","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664877125","title":"SRX Global Provides Shareholder Update on Portfolio Company, ARMR Sciences, a Clinical-Stage Biodefense Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2664877125","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664877125?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:15","pubTimestamp":1788437700,"startTime":"0","endTime":"0","summary":"NORTH PALM BEACH, Fla., Sept.  03, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the “Company” or “SRX”), an AI-enabled platform dedicated to generating long-term shareholder value t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/03/3355886/0/en/srx-global-provides-shareholder-update-on-portfolio-company-armr-sciences-a-clinical-stage-biodefense-company.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","LU1878469433.USD","MIDD","LU2211817866.USD","BK4161","LU1721429402.USD","BK4585","BK4588","LU1721429741.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664877182","title":"Replimune to Present at the Cantor Global Healthcare Conference 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2664877182","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664877182?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:00","pubTimestamp":1788436800,"startTime":"0","endTime":"0","summary":"WOBURN, Mass., Sept.  03, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a commercial stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today a","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/03/3355852/0/en/replimune-to-present-at-the-cantor-global-healthcare-conference-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128526141.USD","LABU","BK4585","HCSG","BK4581","REPL","XLV","BK4588","LU0029874061.USD","BK4137","XBI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664877127","title":"Altimmune to Participate in the Wells Fargo 21st Annual Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664877127","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664877127?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:00","pubTimestamp":1788436800,"startTime":"0","endTime":"0","summary":"GAITHERSBURG, Md., Sept.  03, 2026 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases, today an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/03/3355826/0/en/altimmune-to-participate-in-the-wells-fargo-21st-annual-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KBWB","LU0128525689.USD","LU0256863811.USD","LU1267930490.SGD","LU1506573853.SGD","BK4504","IE00B19Z3581.USD","LABU","LU0106831901.USD","LU0208291251.USD","LU2361044865.SGD","LU0130102774.USD","LU0154236417.USD","LU0320765489.SGD","LU0971096721.USD","LU0640476718.USD","BK4501","LU0310799852.SGD","LU0417517546.SGD","LU2236285917.USD","LU0162691827.USD","LU1035773651.USD","IYF","LU1280957306.USD","LU0072461881.USD","LU2361045086.USD","LU0029864427.USD","LU0251131958.USD","FTXO","LU0310800965.SGD","TFNS","BK4588","WFC","LU0267386448.USD","LU0310800379.SGD","BK4581","XBI","ALD","LU0708994859.HKD","LU0128526141.USD","LU1668664300.SGD","LU1201861249.SGD","LU0942090050.USD","HCSG","PGF","LU0648001328.SGD","XLV","LU0787776722.HKD","BK4207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664771588","title":"Tectonic Therapeutic to Participate in the Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664771588","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664771588?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:00","pubTimestamp":1788436800,"startTime":"0","endTime":"0","summary":"Investors:. Dan Ferry. LifeSci Advisors. (617) 430-7576. Media:. Kathryn Morris. The Yates Network. (914) 204-6412","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/03/3355846/0/en/tectonic-therapeutic-to-participate-in-the-morgan-stanley-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","LU1720051017.SGD","KBWB","IE00BKVL7J92.USD","LABU","BK4581","TECX","MS","LU0795875086.SGD","LU0557290698.USD","LU1064131342.USD","BK4585","BK4588","LU1244550221.USD","LU1363072403.SGD","IE00B3S45H60.SGD","LU2089284900.SGD","LU2357305700.SGD","LU1074936037.SGD","LU2487616109.SGD","LU0029874061.USD","LU1720051108.HKD","BK4127","LU1732800096.USD","BK4137","LU1668664300.SGD","LU1989772923.USD","LU2111349929.HKD","LU0106831901.USD","HCSG","LU1244550494.USD","LU0314104364.USD","LU0267386448.USD","LU0158827948.USD","LU1548497426.USD","LU2271345857.HKD","BK4504","LU0210528500.USD","LU1988902786.USD","LU2028103732.USD","LU1791710582.SGD","LU0128526141.USD","LU2264538146.SGD","LU0528227936.USD","BK4534","IAI","BK4516","XLV","LU1162221912.USD","IE00B775SV38.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664136877","title":"Grace Therapeutics to Participate in the H.C. Wainright 28th Annual Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664136877","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664136877?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:00","pubTimestamp":1788436800,"startTime":"0","endTime":"0","summary":"PRINCETON, N.J., Sept.  03, 2026 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, n","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/03/3355844/0/en/grace-therapeutics-to-participate-in-the-h-c-wainright-28th-annual-global-investment-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4585","LABU","BK4139","BK4007","BK4588","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664871468","title":"Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and Lifecore Biomedical (LFCR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664871468","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664871468?lang=en_us&edition=fundamental","pubTime":"2026-09-03 19:50","pubTimestamp":1788436225,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Ultragenyx Pharmaceutical (RARE) and Lifecore Biomedical (LFCR). ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ultragenyx-pharmaceutical-rare-and-lifecore-biomedical-lfcr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ultragenyx-pharmaceutical-rare-and-lifecore-biomedical-lfcr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4581","BK4121","RARE","BK4212","LU0029874061.USD","BK4137","XLV","LABU","BK4588","HCSG","BK4585","BK4139","XBI","LFCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664687905","title":"DiagnosTear Seeks FDA Guidance for TeaRx Red Eye Diagnostic Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2664687905","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664687905?lang=en_us&edition=fundamental","pubTime":"2026-09-03 19:37","pubTimestamp":1788435462,"startTime":"0","endTime":"0","summary":"The latest update is out from DiagnosTear Technologies, Inc. ( ($TSE:DTR) ). DiagnosTear Technologies has filed a pre-submission request with the U...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/diagnostear-seeks-fda-guidance-for-tearx-red-eye-diagnostic-test?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/diagnostear-seeks-fda-guidance-for-tearx-red-eye-diagnostic-test?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664887183","title":"Liquidia granted Fast Track designation to Yutrepia inhalation powder","url":"https://stock-news.laohu8.com/highlight/detail?id=2664887183","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664887183?lang=en_us&edition=fundamental","pubTime":"2026-09-03 19:35","pubTimestamp":1788435315,"startTime":"0","endTime":"0","summary":"Liquidia (LQDA) announced that the FDA has granted Fast Track designation to Yutrepia inhalation powder for the treatment of Raynaud’s phenomenon a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/liquidia-granted-fast-track-designation-to-yutrepia-inhalation-powder-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/liquidia-granted-fast-track-designation-to-yutrepia-inhalation-powder-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4007","BK4585","BK4588","LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664790228","title":"Analysts Conflicted on These Healthcare Names: Definitive Healthcare Corp (DH) and Entrada Therapeutics Inc (TRDA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664790228","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664790228?lang=en_us&edition=fundamental","pubTime":"2026-09-03 19:30","pubTimestamp":1788435019,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Definitive Healthcare Corp (DH) and Entrada Therap...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-definitive-healthcare-corp-dh-and-entrada-therapeutics-inc-trda-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-definitive-healthcare-corp-dh-and-entrada-therapeutics-inc-trda-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4581","DH","XBI","BK4167","LABU","BK4139","BK4585","TRDA","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664687659","title":"American Healthcare REIT acquires eight senior housing communities for $696M","url":"https://stock-news.laohu8.com/highlight/detail?id=2664687659","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664687659?lang=en_us&edition=fundamental","pubTime":"2026-09-03 18:35","pubTimestamp":1788431708,"startTime":"0","endTime":"0","summary":"American Healthcare REIT (AHR) announced the acquisition of eight Class A senior housing communities for approximately $696M, establishing a new op...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/american-healthcare-reit-acquires-eight-senior-housing-communities-for-696m-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/american-healthcare-reit-acquires-eight-senior-housing-communities-for-696m-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IQRA","AHR","BK4225","RNTY","MDIV","XLV","REIT","PSCF","BK4581","YLDW","BK4585","BK4588","BPRE","DFRA","XBI","HLGE","RJMG","REZ","LABU","IVRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664875422","title":"EPF Trims IHH Healthcare Stake but Retains Strong Institutional Holding","url":"https://stock-news.laohu8.com/highlight/detail?id=2664875422","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664875422?lang=en_us&edition=fundamental","pubTime":"2026-09-03 18:17","pubTimestamp":1788430678,"startTime":"0","endTime":"0","summary":"IHH Healthcare Bhd ( ($IHHHF) ) just unveiled an announcement. Malaysia’s Employees Provident Fund Board has marginally reduced its direct stake in...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/epf-trims-ihh-healthcare-stake-but-retains-strong-institutional-holding?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/epf-trims-ihh-healthcare-stake-but-retains-strong-institutional-holding?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","LU0029874061.USD","BK4585","XLV","XBI","BK4588","BK4581","BK4137","HCSG","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664487549","title":"BioLargo subsidiary adds third distribution channel, accelerate ViaClyr rollout","url":"https://stock-news.laohu8.com/highlight/detail?id=2664487549","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664487549?lang=en_us&edition=fundamental","pubTime":"2026-09-03 18:15","pubTimestamp":1788430536,"startTime":"0","endTime":"0","summary":"BioLargo (BLGO) announced that its subsidiary Clyra Medical Technologies is expanding distribution of its FDA-cleared ViaClyr wound irrigation solu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biolargo-subsidiary-adds-third-distribution-channel-accelerate-viaclyr-rollout-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biolargo-subsidiary-adds-third-distribution-channel-accelerate-viaclyr-rollout-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BLGO","BK4588","BK4109","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664730678","title":"Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST) and Alumis Inc. (ALMS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664730678","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664730678?lang=en_us&edition=fundamental","pubTime":"2026-09-03 17:40","pubTimestamp":1788428406,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Envista Holdings (NVST) and Alumis Inc. (ALMS). En...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-envista-holdings-nvst-and-alumis-inc-alms-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-envista-holdings-nvst-and-alumis-inc-alms-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","HCSG","LU0128526141.USD","LU0130518102.USD","LU0130103400.USD","BK4588","BK4585","XBI","IE00B19Z6F94.USD","BK4007","BK4581","BK4137","ALMS","BK4082","LU1201861165.SGD","LABU","LU0477156797.USD","LU0648000940.SGD","NVST","XLV","IE0034390439.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":12,"totalSize":419,"code":"91000000","status":"200"}]}}